At the Phage Therapy Laboratory, we are working to promote phage therapy in Israel and worldwide. We work with a variety of pathogenic and environmental bacteria and study their interactions with phage. As part of our laboratory research, we isolate new phages from nature and characterize them using molecular, microbiological, virological, and microscopic methods. We study a variety of delivery routes, phage stability, and their efficacy against a wide range of pathogens in vitro and in vivo experiments.

Due to the high specificity of phages and to achieve optimal results, we adopted a personalized treatment approach. A key element of this approach is the development of a large phage bank.

Therefore, we established the Israeli Phage Bank (IPB), which is one of the largest in the world and contains over 500 phages against a broad spectrum of bacteria. The phages were collected using traditional methods and new sophisticated screening methods that we developed specifically for this project.

With these phages, we have so far treated 13 patients in Israel and have been involved in the treatment of several patients around the world, including the United States, Australia and Germany. In addition, the phages from the bank are currently being used for various studies and veterinary applications.

In addition to the use of phages in human medicine, we are also investigating other applications in areas such as agriculture, veterinary medicine and more.

Although we are mainly concerned with phages in the laboratory, there are other areas of interest. One important and exciting area is bioarchaeology.